1. Deep immune profiling of ovarian tumors identifies minimal MHC-I expression after neoadjuvant chemotherapy as negatively associated with T-cell-dependent outcome

   Merkus-Brunekreeft, K., Paijens, S., Wouters, M., Komdeur, F., Eggink, F., Lubbers-Marsman, J., Workel, H., Slikke, van der, E. C., Propper, N. E. J., Leffers, N., Adam, J., Pijper, H., Plat, A., Kol, A., Nijman, H. & Bruyn, de, M., 13-May-2020, In : OncoImmunology. 9, 1, 1760705.

   Research output: Contribution to journal › Article › Academic › peer-review

2. GUIDLINE ADHERENCE AND SURVIVAL IN LOCALLY ADVANCED CERVICAL CANCER IN THE NETHERLANDS BETWEEN 2009-2016

   Wenzel, H., Bekkers, R., Lemmens, V., Nijman, H. & van der Aa, M., Nov-2019, In : International Journal of Gynecological Cancer. 29, p. A79-A81 4 p., P47.

   Research output: Contribution to journal › Meeting Abstract › Academic

3. Endometrial Cancer Molecular Risk Stratification is Equally Prognostic for Endometrioid Ovarian Carcinoma

   Krämer, P., Talhouk, A., Brett, M. A., Chiu, D. S., Cairns, E. S., Scheunhage, D. A., Hammond, R. F., Farnell, D., Nazeran, T. M., Grube, M., Xia, Z., Senz, J., Leung, S., Feil, L., Pasternak, J., Dixon, K., Hartkopf, A., Krämer, B., Brucker, S., Heitz, F., du Bois, A., Harter, P., Kommoss, F., Sinn, H-P., Heublein, S., Kommoss, F., Vollert, H-W., Manchanda, R., de Kroon, C. D., Nijman, H. W., de Bruyn, M., Thompson, E. F., Bashashati, A., McAlpine, J. N., Singh, N., Tinker, A. V., Staebler, A., Bosse, T., Kommoss, S., Köbel, M. & Anglesio, M. S., 31-Jul-2020, In : Clinical Cancer Research. 29 p.

   Research output: Contribution to journal › Article › Academic › peer-review

4. Deep immune profiling of ovarian tumors identifies minimal MHC-I expression after neoadjuvant chemotherapy as negatively associated with T-cell-dependent outcome

   Brunekreeft, K. L., Paijens, S. T., Wouters, M. C. A., Komdeur, F. L., Eggink, F. A., Lubbers, J. M., Workel, H. H., Van der Slikke, E. C., Propper, N. E. J., Leffers, N., Adam, J., Pijper, H., Plat, A., Kol, A., Nijman, H. W. & De Bruyn, M., 1-Jan-2020, In : OncoImmunology. 9, 1, 12 p., 1760705.

   Research output: Contribution to journal › Article › Academic › peer-review

5. Cervical cancer with ≤5 mm depth of invasion and >7 mm horizontal spread - Is lymph node assessment only required in patients with LVSI?

   Wenzel, H. H. B., Van Kol, K. G. G., Nijman, H. W., Lemmens, V. E. P. P., Van der Aa, M. A., Ebisch, R. M. F. & Bekkers, R. L. M., Aug-2020, In : Gynecologic Oncology. 158, 2, p. 282-286 5 p.

   Research output: Contribution to journal › Article › Academic › peer-review

View all (172) »

1. Interview bij ZonMW

   Hans Nijman

   20/09/2019

   1 Media contribution

   Press/Media: Public Engagement Activities › Professional

2. Immunoncologie artikel therapeutisch HPV vaccin voor cervixcarcinoom

   Hans Nijman

   25/08/2019

   1 item of Media coverage

   Press/Media: Research › Professional

3. Kankervaccin klaar voor tests op patiënten

   Toos Daemen & Hans Nijman

   18/04/2016

   1 item of Media coverage

   Press/Media: Research › Popular

View all (3) »

1. Gynaecongres

   Hans Nijman (Invited speaker)

   17-May-2019

   Activity: Participating in or organising an event › Participation in conference › Professional

2. Olijf congresdag 2019

   Hans Nijman (Invited speaker)

   28-Sep-2019

   Activity: Participating in or organising an event › Participation in conference › Academic

3. Refereeravond vulvapathologie

   Hans Nijman (Consultant)

   23-Jan-2019

   Activity: Consultancy › Professional

View all (48) »